Related references
Note: Only part of the references are listed.Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology
Philipp Nuhn et al.
EUROPEAN UROLOGY (2019)
Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells
Kenichiro Ishii et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Recent Advances in Prostate Cancer Treatment and Drug Discovery
Ekaterina Nevedomskaya et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Interleukin-6 induces VEGF secretion from prostate cancer cells in a manner independent of androgen receptor activation
Kenichiro Ishii et al.
PROSTATE (2018)
Intratumor heterogeneity in prostate cancer
Shalini S. Yadav et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2018)
Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer
Howard I. Scher et al.
JAMA ONCOLOGY (2018)
Role of Stromal Paracrine Signals in Proliferative Diseases of the Aging Human Prostate
Kenichiro Ishii et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Castration-Resistant Prostate Cancer Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents: Opportunities and Challenges
Yuki Kita et al.
CANCERS (2018)
Androgen Receptor Splice Variant 7 Drives the Growth of Castration Resistant Prostate Cancer without Being Involved in the Efficacy of Taxane Chemotherapy
Yasuomi Shimizu et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy
Shuang G. Zhao et al.
JAMA ONCOLOGY (2017)
Fibroblasts prolong serum prostate-specific antigen decline after androgen deprivation therapy in prostate cancer
Takeshi Sasaki et al.
LABORATORY INVESTIGATION (2016)
Metastatic castration-resistant prostate cancer (CRPC): preclinical and clinical evidence for the sequential use of novel therapeutics
Deborah Mukherji et al.
CANCER AND METASTASIS REVIEWS (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependent
Twana Alkasalias et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples
Giovanni Luca Gravina et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Phase III, Randomized, Placebo-Controlled Study of Docetaxel in Combination With Zibotentan in Patients With Metastatic Castration-Resistant Prostate Cancer
Karim S. Fizazi et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2012)
Cutoff value of time to prostate-specific antigen nadir is inversely correlated with disease progression in advanced prostate cancer
Takeshi Sasaki et al.
ENDOCRINE-RELATED CANCER (2012)
Low Androgen Sensitivity Is Associated With Low Levels of Akt Phosphorylation in LNCaP-E9 Cells
Kazuhiro Iguchi et al.
JOURNAL OF ANDROLOGY (2012)
Molecular States Underlying Androgen Receptor Activation: A Framework for Therapeutics Targeting Androgen Signaling in Prostate Cancer
Peter S. Nelson
JOURNAL OF CLINICAL ONCOLOGY (2012)
Characterization of the low pH/low nutrient-resistant LNCaP cell subline LNCaP-F10
Kazuhiro Iguchi et al.
ONCOLOGY REPORTS (2012)
Role for Stromal Heterogeneity in Prostate Tumorigenesis
Maria A. Kiskowski et al.
CANCER RESEARCH (2011)
Altered TGF-β Signaling in a Subpopulation of Human Stromal Cells Promotes Prostatic Carcinogenesis
Omar E. Franco et al.
CANCER RESEARCH (2011)
What is the pathophysiology of a hormone-resistant prostate tumour?
Bertrand Tombal
EUROPEAN JOURNAL OF CANCER (2011)
High-throughput live-cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts
Emilie Flaberg et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Heterogenous Induction of Carcinoma-Associated Fibroblast-Like Differentiation in Normal Human Prostatic Fibroblasts by Co-Culturing With Prostate Cancer Cells
Kenichiro Ishii et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Effects of Androgen Receptor and Androgen on Gene Expression in Prostate Stromal Fibroblasts and Paracrine Signaling to Prostate Cancer Cells
Matthew J. Tanner et al.
PLOS ONE (2011)
Nadir PSA level and time to PSA nadir following primary androgen deprivation therapy are the early survival predictors for prostate cancer patients with bone metastasis
T. Sasaki et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2011)
Androgen receptor W741C and T877A mutations in AIDL cells, an androgen-independent subline of prostate cancer LNCaP cells
Takashi Otsuka et al.
TUMOR BIOLOGY (2011)
The relevance of a hypoxic tumour microenvironment in prostate cancer
Grant D. Stewart et al.
BJU INTERNATIONAL (2010)
N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer
Karin Jennbacken et al.
ENDOCRINE-RELATED CANCER (2010)
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
Shihua Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
Zhiyong Guo et al.
CANCER RESEARCH (2009)
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2009)
Evidence that androgen-independent stromal growth factor signals promote androgen-insensitive prostate cancer cell growth in vivo
Kenichiro Ishii et al.
ENDOCRINE-RELATED CANCER (2009)
Molecular mechanisms of castration-resistant prostate cancer progression
Smitha S. Dutt et al.
FUTURE ONCOLOGY (2009)
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
Scott M. Dehm et al.
CANCER RESEARCH (2008)
Androgen receptor and growth factor signaling cross-talk in prostate cancer cells
Meng-Lei Zhu et al.
ENDOCRINE-RELATED CANCER (2008)
Isolation and characterization of LNCaP sublines differing in hormone sensitivity
Kazuhiro Iguchi et al.
JOURNAL OF ANDROLOGY (2007)
Androgen-insensitive prostate cancer cells transiently respond to castration treatment when growing in an androgen-dependent prostate environment
Sofia Halin et al.
PROSTATE (2007)
Degradation and beyond: Control of androgen receptor activity by the proteasome system
Tomasz Jaworski
CELLULAR & MOLECULAR BIOLOGY LETTERS (2006)
Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer
MA Titus et al.
CLINICAL CANCER RESEARCH (2005)
Mechanisms of the development of androgen independence in prostate cancer
A So et al.
WORLD JOURNAL OF UROLOGY (2005)
Prostate specific antigen gene regulation by androgen receptor
J Kim et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Suppression versus induction of androgen receptor functions by the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer LNCaP cells with different passage numbers
HK Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Role of the stromal microenvironment in carcinogenesis of the prostate
GR Cunha et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Tumor hypoxia: A target for selective cancer therapy
S Kizaka-Kondoh et al.
CANCER SCIENCE (2003)
Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells
T Ueda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Androgen receptors in prostate cancer
Z Culig et al.
ENDOCRINE-RELATED CANCER (2002)
Studies on prostatic cancer - I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate
C Huggins et al.
JOURNAL OF UROLOGY (2002)
The development of androgen-independent prostate cancer
BJ Feldman et al.
NATURE REVIEWS CANCER (2001)
Mitogen-activated protein kinase pathway is involved in α6 integrin gene expression in androgen-independent prostate cancer cells:: role of proximal Sp1 consensus sequence
T Onishi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2001)
Share Paper
